Found 24 matching trials
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) EARLY_PHASE1 The goal of this phase 0 proof-of concept study is to measure the therapeut...
Show More Location
Division of Nuclear Medicine, University Hospital Basel
Learn More & Join Trial
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs PHASE2 This study is to assess if personalized peptide receptor radionuclide thera...
Show More Learn More & Join Trial
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer PHASE3 DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTA...
Show More Location
CHU Grenoble Alpes
Learn More & Join Trial
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer PHASE2 This is a non-randomized, phase II, open label study. The purpose of this s...
Show More Location
Centrum Diagnostyczno-Lecznicze Gammed
Learn More & Join Trial
Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery PHASE1 The purpose of this study is to learn about the feasibility and safety of u...
Show More Status
Active Not Recruiting
Location
Stanford Cancer Institute Palo Alto
Learn More & Join Trial
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. PHASE3 LEVEL trial aims to demonstrate the higher efficacy of 177Lu-edotreotide ov...
Show More Location
Antwerp University Hospital (UZA)
Learn More & Join Trial
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors PHASE1 The purpose of the study is to determine the appropriate pediatric dosage a...
Show More Location
UCSF Benioff Children's Hospital
Learn More & Join Trial
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. PHASE1 This phase I trial tests the safety and effectiveness of stereotactic body ...
Show More Location
Emory University Hospital Midtown
Learn More & Join Trial
Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients PHASE2 In this study, we want to randomize patients with neuroendocrine neoplasms ...
Show More Location
Aarhus University Hospital, department of Nuclear medicine and PET centre
Learn More & Join Trial
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2) NA The rationale behind the purpose of this study lays on:
* the evidence tha...
Show More Location
University Hospital of Ferrara
Learn More & Join Trial